Trials / Terminated
TerminatedNCT00298805
A Quality of Life Study in Patients With Migraines
Dysphoric-like Disorder of Epilepsy, Is It Unique?
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare depressive characteristics in migraine patients to those observed in patients with epilepsy in a previous study, and determine whether those symptoms are unique to patients with epilepsy.
Detailed description
A form of depression known as dysphoric-like disorder is common in people with epilepsy, which may significantly affect the quality of life in these people, as shown in a previous study. However, it is unclear if this depressive disorder is unique to patients with epilepsy. In order to assess whether these symptoms are unique and idiosyncratic to the epilepsy population, in this multi-center study, these dysphoric depressive features will be contrasted to those seen in patients with other neurologic or psychiatric conditions. Migraine is selected as one of the comparison disorders because it shares with epilepsy characteristics of being a recurrent episodic central nervous system disorder, and our site will only enroll patients with migraine headaches.
Conditions
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2009-06-01
- Completion
- 2013-04-01
- First posted
- 2006-03-03
- Last updated
- 2013-08-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00298805. Inclusion in this directory is not an endorsement.